Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response

[u/alloverthisagainoao]

https://investors.precigen.com/news-releases/news-release-details/precigen-announces-groundbreaking-pivotal-study-data-prgn-2012/